Literature DB >> 9437509

Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells.

M Terada1, M Inaba, Y Yano, T Hasuma, Y Nishizawa, H Morii, S Otani.   

Abstract

Impaired bone formation resulting from a decline of osteoblast activity has been implicated in the pathogenesis of diabetic osteopenia. We examined the effects of high glucose concentration alone, independent of insulin deficiency, on the growth of a human osteoblast-like cell line (MG-63). Sustained exposure to high glucose for 7 days inhibited cell growth in a concentration-dependent manner up to 49.5 mmol/L, as compared with cells cultured with a normal glucose concentration (5.5 mmol/L) or a high mannitol concentration (an iso-osmolar control). Glucose (49.5 mmol/L) attenuated the increment either in DNA content or in [3H]thymidine incorporation induced by insulin-like growth factor I (IGF-I). The IGF-I-induced increase of ornithine decarboxylase (ODC) activity, which plays an important role in cell growth, was also attenuated. The half-life of ODC protein was not shortened by the high glucose culture, but the intracellular content of putrescine (an end product of ODC) was significantly decreased. These changes did not occur in the high mannitol culture, strongly suggesting a specific effect of glucose. In summary, our observations suggest that a high glucose concentration significantly impairs the proliferative response of osteoblastic cells to IGF-I and that the defective cell function caused by sustained exposure to high glucose levels might contribute to impaired bone formation in patients with diabetic osteopenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9437509     DOI: 10.1016/s8756-3282(97)00220-2

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  39 in total

1.  Bone fragility in type 2 diabetes mellitus.

Authors:  Toru Yamaguchi
Journal:  World J Orthop       Date:  2010-11-18

2.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

3.  Bone cells and bone turnover in diabetes mellitus.

Authors:  Mishaela R Rubin
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

4.  Bone structure and turnover in type 2 diabetes mellitus.

Authors:  A Shu; M T Yin; E Stein; S Cremers; E Dworakowski; R Ives; M R Rubin
Journal:  Osteoporos Int       Date:  2011-03-19       Impact factor: 4.507

5.  Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes.

Authors:  Shin Takaoka; Toru Yamaguchi; Ken-Ichiro Tanaka; Miwa Morita; Masahiro Yamamoto; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2012-10-17       Impact factor: 2.626

6.  High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63 cells through cAMP/protein kinase A/extracellular signal-regulated kinase pathway.

Authors:  Weiwei Wang; Xiaolin Zhang; Jiaqiang Zheng; Jianhong Yang
Journal:  Mol Cell Biochem       Date:  2009-12-01       Impact factor: 3.396

7.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

8.  Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation.

Authors:  Ignazio Barbagallo; Angelo Vanella; Stephen J Peterson; Dong Hyun Kim; Daniele Tibullo; Cesarina Giallongo; Luca Vanella; Nunziatina Parrinello; Giuseppe A Palumbo; Francesco Di Raimondo; Nader G Abraham; David Asprinio
Journal:  J Bone Miner Metab       Date:  2009-11-19       Impact factor: 2.626

9.  Peroxynitrite mediates high glucose-induced osteoblast apoptosis.

Authors:  J S Qi; Y N Li; B S Zhang; T Niu; J H Liang
Journal:  J Endocrinol Invest       Date:  2008-04       Impact factor: 4.256

10.  HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage.

Authors:  Luca Vanella; Dong Hyun Kim; David Asprinio; Stephen J Peterson; Ignazio Barbagallo; Angelo Vanella; Dove Goldstein; Susumu Ikehara; Attallah Kappas; Nader G Abraham
Journal:  Bone       Date:  2009-10-21       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.